» Articles » PMID: 1829808

FMS (CSF-1 Receptor) and CSF-1 Transcripts and Protein Are Expressed by Human Breast Carcinomas in Vivo and in Vitro

Overview
Journal Oncogene
Date 1991 Jun 1
PMID 1829808
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The expression in vivo of FMS transcripts and antigen by neoplastic epithelial cells was demonstrated immunohistochemically or by in situ hybridization in sixteen of seventeen human breast carcinoma specimens and one case of sclerosing adenosis. Expression of CSF-1 receptor (FMS) transcripts and protein was also observed in vitro in two or three breast carcinoma-derived cell lines and was dramatically increased by dexamethasone, a potent glucocorticoid and inducer of mammary epithelial cell differentiation. Immunohistochemical staining with an anti-CSF-1 antibody identified neoplastic epithelial cell co-expression of fms and CSF-1 antigens in more than one-third of the fms-positive invasive carcinoma specimens. These results suggest that autocrine and paracrine interactions of the lymphohematopoietic cytokine CSF-1 and its receptor may participate in the biology of human mammary neoplasms.

Citing Articles

Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect.

Chompunud Na Ayudhya C, Graidist P, Tipmanee V Sci Rep. 2024; 14(1):12531.

PMID: 38822100 PMC: 11143223. DOI: 10.1038/s41598-024-63505-x.


A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with Melanoma.

Buchbinder E, Giobbie-Hurder A, Haq R, Ott P Invest New Drugs. 2023; 41(4):551-555.

PMID: 37247116 DOI: 10.1007/s10637-023-01374-3.


A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibition.

Buchbinder E, Giobbie-Hurder A, Ott P Invest New Drugs. 2023; 41(3):365-370.

PMID: 37097370 DOI: 10.1007/s10637-023-01364-5.


Regulation of closely juxtaposed proto-oncogene and gene expression by mRNA 3' end polymorphism in breast cancer cells.

Woo H, Chambers S RNA. 2021; 27(9):1068-1081.

PMID: 34155128 PMC: 8370744. DOI: 10.1261/rna.078749.121.


Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.

Murga-Zamalloa C, Rolland D, Polk A, Wolfe A, Dewar H, Chowdhury P Clin Cancer Res. 2019; 26(3):690-703.

PMID: 31636099 PMC: 7002219. DOI: 10.1158/1078-0432.CCR-19-1486.